Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19
Clinical trial NCT04684446 · COMPLETED
Trial details
- NCT number
- NCT04684446
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2021-11-26
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.